Teresa A. Colvin, Ph.D. - Publications

Affiliations: 
2014 Molecular Medicine GMS Boston University, Boston, MA, United States 
Area:
Biochemistry, Medicine and Surgery, Oncology

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Gabai VL, Yaglom J, Wang Y, Meng L, Shao H, Kim G, Colvin T, Gestwicki J, Sherman MY. Anti-cancer effects of targeting Hsp70 in tumor stromal cells. Cancer Research. PMID 27503927 DOI: 10.1158/0008-5472.Can-16-0800  0.431
2015 Li X, Colvin T, Rauch JN, Acosta-Alvear D, Kampmann M, Dunyak B, Hann B, Aftab BT, Murnane M, Cho M, Walter P, Weissman JS, Sherman MY, Gestwicki JE. Validation of the hsp70-bag3 protein-protein interaction as a potential therapeutic target in cancer. Molecular Cancer Therapeutics. 14: 642-8. PMID 25564440 DOI: 10.1158/1535-7163.Mct-14-0650  0.478
2014 Colvin TA, Gabai VL, Gong J, Calderwood SK, Li H, Gummuluru S, Matchuk ON, Smirnova SG, Orlova NV, Zamulaeva IA, Garcia-Marcos M, Li X, Young ZT, Rauch JN, Gestwicki JE, et al. Hsp70-Bag3 interactions regulate cancer-related signaling networks. Cancer Research. 74: 4731-40. PMID 24994713 DOI: 10.1158/0008-5472.Can-14-0747  0.451
2014 Colvin TA, Gabai VL, Sherman MY. Proteotoxicity is not the reason for the dependence of cancer cells on the major chaperone Hsp70. Cell Cycle (Georgetown, Tex.). 13: 2306-10. PMID 24911412 DOI: 10.4161/Cc.29296  0.463
Show low-probability matches.